CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Norton Healthcare

Marti Gardner, System Director, Clinical Research Operations

A Vision for the Future of Clinical Research

Marti Gardner

Marti Gardner

Marti Gardner serves as the System Director of Clinical Research Operations at Norton Healthcare, combining strategic leadership with a passion for enhancing patient care through research. With extensive experience in healthcare management, she ensures the seamless integration of clinical trials into the healthcare system. This provides patients access to groundbreaking treatments without the need to travel far.


Marti is dedicated to improving the efficiency and accessibility of clinical research, whether through adopting new technologies or optimizing operational processes. Her collaborative approach, both with her team and external partners, aims to advance medical research and improve patient outcomes.


Expanding Access to Advanced Medical Treatments


I lead a dedicated team of 135 clinical staff with the mission of expanding access to innovative treatments through a wide range of clinical research. This includes phase I to IV investigational drug studies, device trials, and more.


My daily focus is on empowering my team to overcome any obstacles in trial activation and patient enrollment, ensuring that every patient has access to life-changing therapies right where they are.


Innovating Specialty Care


Under my leadership, specialized teams in areas like cardiovascular care, pulmonary hypertension, and oncology have expanded access to advanced treatments.


Whether it's through device trials for heart failure, our involvement in the development of FDA-approved pulmonary hypertension drugs, or offering early-phase cancer trials, we aim to provide patients with cutting-edge therapies.


Our goal is to ensure they receive these treatments while staying close to home and surrounded by their support systems.


Our goal is to ensure they receive these treatments while staying close to home and surrounded by their support systems.


Building Trust and Overcoming Challenges


I believe in eliminating barriers for both investigators and patients. Streamlining clinical responsibilities and ensuring trials are aligned with patient needs are at the heart of our work.


Clear communication with sponsors builds trust and ensures that we only take on trials we are fully equipped to support, which leads to successful enrollments and smooth trial execution.


Leveraging Technology for Future Success


Looking to the future, I see technology playing a bigger role in clinical trials. The integration of electronic health records (EHR) and electronic data capture (EDC) systems will boost efficiency, improve data sharing, and reduce errors.


My focus will be on ensuring that both our staff and research participants are well-supported as trials grow more complex.


Bringing Specialized Care to Local Communities


I am incredibly proud of our pediatric research program, which is anchored by the largest children’s hospital in the state. This program plays a significant role in improving our hospital’s national rankings and ensures that families have access to clinical trials locally.


We help ensure that children receive the latest treatments without the need for travel, which is a crucial part of our mission to provide exceptional care by offering specialized care close to home.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cxoinsight/a-vision-for-the-future-of-clinical-research-nwid-2514.html